PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIS vs. RSPN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIS and RSPN is -0.51. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-0.5

Performance

BIS vs. RSPN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%500.00%JulyAugustSeptemberOctoberNovemberDecember
-99.60%
432.09%
BIS
RSPN

Key characteristics

Sharpe Ratio

BIS:

-0.21

RSPN:

1.52

Sortino Ratio

BIS:

-0.06

RSPN:

2.20

Omega Ratio

BIS:

0.99

RSPN:

1.27

Calmar Ratio

BIS:

-0.07

RSPN:

2.57

Martin Ratio

BIS:

-0.38

RSPN:

8.27

Ulcer Index

BIS:

19.62%

RSPN:

2.62%

Daily Std Dev

BIS:

35.63%

RSPN:

14.23%

Max Drawdown

BIS:

-99.77%

RSPN:

-61.64%

Current Drawdown

BIS:

-99.71%

RSPN:

-7.52%

Returns By Period

In the year-to-date period, BIS achieves a 4.00% return, which is significantly lower than RSPN's 18.99% return. Over the past 10 years, BIS has underperformed RSPN with an annualized return of -20.64%, while RSPN has yielded a comparatively higher 10.94% annualized return.


BIS

YTD

4.00%

1M

4.82%

6M

10.56%

1Y

-4.31%

5Y*

-18.28%

10Y*

-20.64%

RSPN

YTD

18.99%

1M

-4.14%

6M

11.62%

1Y

20.30%

5Y*

13.65%

10Y*

10.94%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIS vs. RSPN - Expense Ratio Comparison

BIS has a 0.95% expense ratio, which is higher than RSPN's 0.40% expense ratio.


BIS
ProShares UltraShort Nasdaq Biotechnology
Expense ratio chart for BIS: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for RSPN: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%

Risk-Adjusted Performance

BIS vs. RSPN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIS, currently valued at -0.21, compared to the broader market0.002.004.00-0.211.52
The chart of Sortino ratio for BIS, currently valued at -0.06, compared to the broader market-2.000.002.004.006.008.0010.00-0.062.20
The chart of Omega ratio for BIS, currently valued at 0.99, compared to the broader market0.501.001.502.002.503.000.991.27
The chart of Calmar ratio for BIS, currently valued at -0.07, compared to the broader market0.005.0010.0015.00-0.072.57
The chart of Martin ratio for BIS, currently valued at -0.38, compared to the broader market0.0020.0040.0060.0080.00100.00-0.388.27
BIS
RSPN

The current BIS Sharpe Ratio is -0.21, which is lower than the RSPN Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of BIS and RSPN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.21
1.52
BIS
RSPN

Dividends

BIS vs. RSPN - Dividend Comparison

BIS's dividend yield for the trailing twelve months is around 2.58%, more than RSPN's 0.65% yield.


TTM202320222021202020192018
BIS
ProShares UltraShort Nasdaq Biotechnology
2.58%1.75%0.00%0.00%0.44%2.10%0.37%
RSPN
Invesco S&P 500® Equal Weight Industrials ETF
0.65%0.55%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BIS vs. RSPN - Drawdown Comparison

The maximum BIS drawdown since its inception was -99.77%, which is greater than RSPN's maximum drawdown of -61.64%. Use the drawdown chart below to compare losses from any high point for BIS and RSPN. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.71%
-7.52%
BIS
RSPN

Volatility

BIS vs. RSPN - Volatility Comparison

ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 11.55% compared to Invesco S&P 500® Equal Weight Industrials ETF (RSPN) at 4.60%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than RSPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
11.55%
4.60%
BIS
RSPN
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab